{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:14:22Z","timestamp":1792592062825,"version":"4.5.0"},"reference-count":149,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T00:00:00Z","timestamp":1713916800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UIDB\/04650\/2020"],"award-info":[{"award-number":["UIDB\/04650\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["2020.06561"],"award-info":[{"award-number":["2020.06561"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advanced Drug Delivery Reviews"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.addr.2024.115321","type":"journal-article","created":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T12:18:56Z","timestamp":1714133936000},"page":"115321","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Recent advances and strategies for nanocarrier-mediated topical therapy and theranostic for posterior eye disease"],"prefix":"10.1016","volume":"210","author":[{"given":"Maria Jo\u00e3o","family":"Faria","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 M.","family":"Gonz\u00e1lez-M\u00e9ijome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Elisabete C.D.","family":"Real Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonzalo","family":"Carracedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2593-1672","authenticated-orcid":false,"given":"Marlene","family":"L\u00facio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2021","key":"10.1016\/j.addr.2024.115321_b0005","first-page":"144","article-title":"Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study","volume":"9","author":"GBD 2019 Blindness and Vision Impairment Collaborators","year":"2019","journal-title":"Lancet Glob. Heal."},{"key":"10.1016\/j.addr.2024.115321_b0010","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s10654-015-0098-2","article-title":"Ophthalmic epidemiology in Europe: the \u201cEuropean Eye Epidemiology\u201d (E3) consortium","volume":"31","author":"Delcourt","year":"2016","journal-title":"Eur. J. Epidemiol."},{"key":"10.1016\/j.addr.2024.115321_b0015","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jconrel.2014.06.043","article-title":"Ocular delivery of macromolecules","volume":"190","author":"Kim","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2024.115321_b0020","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.addr.2018.01.008","article-title":"Ocular delivery of proteins and peptides: challenges and novel formulation approaches","volume":"126","author":"Mandal","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"2021","key":"10.1016\/j.addr.2024.115321_b0025","first-page":"1","article-title":"Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the Global Burden of Disease Study","volume":"9","author":"GBD 2019 Blindness and Vision Impairment Collaborators","year":"2019","journal-title":"Lancet Glob. Heal."},{"key":"10.1016\/j.addr.2024.115321_b0030","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2174\/1872211308666140130093301","article-title":"Drug delivery to the back of the eye following topical administration: an update on research and patenting activity","volume":"8","author":"Boddu","year":"2014","journal-title":"Recent Pat. Drug Deliv. Formul."},{"key":"10.1016\/j.addr.2024.115321_b0035","doi-asserted-by":"crossref","first-page":"47","DOI":"10.5497\/wjp.v2.i2.47","article-title":"Ocular drug delivery systems: an overview","volume":"2","author":"Patel","year":"2013","journal-title":"World J. Pharmacol."},{"key":"10.1016\/j.addr.2024.115321_b0040","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.apsb.2016.09.001","article-title":"Nanotechnology-based strategies for treatment of ocular disease","volume":"7","author":"Weng","year":"2017","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.addr.2024.115321_b0045","series-title":"Lipid Nanocarriers Drug Target","first-page":"269","article-title":"Chapter 7 - Ocular delivery of solid lipid nanoparticles","author":"Battaglia","year":"2018"},{"key":"10.1016\/j.addr.2024.115321_b0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics13050678","article-title":"Lipid-based nanocarriers as topical drug delivery systems for intraocular diseases","volume":"13","author":"Navarro-Partida","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.addr.2024.115321_b0055","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.4155\/tde.14.75","article-title":"Advances in ophthalmic drug delivery","volume":"5","author":"Morrison","year":"2014","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.addr.2024.115321_b0060","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1124\/jpet.119.256933","article-title":"Ocular drug delivery: present innovations and future challenges","volume":"370","author":"Gote","year":"2019","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.addr.2024.115321_b0065","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ijpharm.2017.07.065","article-title":"Non-invasive strategies for targeting the posterior segment of eye","volume":"530","author":"Madni","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2024.115321_b0070","doi-asserted-by":"crossref","first-page":"683","DOI":"10.2217\/nnm-2016-0379","article-title":"Drug delivery to the eye: what benefits do nanocarriers offer?","volume":"12","author":"Joseph","year":"2017","journal-title":"Nanomedicine"},{"key":"10.1016\/j.addr.2024.115321_b0075","doi-asserted-by":"crossref","first-page":"700","DOI":"10.3109\/10717544.2014.923065","article-title":"Colloidal drug delivery system: amplify the ocular delivery","volume":"23","author":"Ameeduzzafar","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.addr.2024.115321_b0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics11090460","article-title":"Advanced formulation approaches for ocular drug delivery: state-of-the-art and recent patents","volume":"11","author":"Souto","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.addr.2024.115321_b0085","first-page":"15492","article-title":"Nanotechnology and nanomedicine: start small, think big","volume":"5","author":"Kargozar","year":"2018","journal-title":"Mater. Today:. Proc."},{"key":"10.1016\/j.addr.2024.115321_b0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fchem.2018.00360","article-title":"Nanomedicine: principles, properties, and regulatory issues","volume":"6","author":"Soares","year":"2018","journal-title":"Front. Chem."},{"key":"10.1016\/j.addr.2024.115321_b0095","unstructured":"Grand View Research Inc., Nanomedicine Market Size Worth, 2022, https:\/\/www.grandviewresearch.com\/press-release\/global-nanomedicine-market."},{"key":"10.1016\/j.addr.2024.115321_b0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/wnan.1548","article-title":"Fundamentals, challenges, and nanomedicine-based solutions for ocular diseases","volume":"11","author":"Srinivasarao","year":"2019","journal-title":"Wiley Interdiscip. Rev. Nanomed. NanoBiotechnol."},{"key":"10.1016\/j.addr.2024.115321_b0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.addr.2023.114770","article-title":"Polymer- and lipid-based nanocarriers for ocular drug delivery: current status and future perspectives","volume":"196","author":"Han","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2024.115321_b0110","doi-asserted-by":"crossref","first-page":"27835","DOI":"10.1039\/D0RA04971A","article-title":"Nanocarriers for ocular drug delivery: current status and translational opportunity","volume":"10","author":"Gorantla","year":"2020","journal-title":"RSC Adv."},{"key":"10.1016\/j.addr.2024.115321_b0115","first-page":"1","article-title":"Lipid nanoparticles for the posterior eye segment","volume":"14","author":"Bonilla","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.addr.2024.115321_b0120","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.biopha.2018.08.138","article-title":"A review on recent drug delivery systems for posterior segment of eye","volume":"107","author":"Nayak","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.addr.2024.115321_b0125","doi-asserted-by":"crossref","first-page":"5403","DOI":"10.1167\/iovs.10-5392","article-title":"Ophthalmic drug delivery systems for the treatment of retinal diseases: basic research to clinical applications","volume":"51","author":"Edelhauser","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.addr.2024.115321_b0130","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.preteyeres.2016.12.001","article-title":"Pharmacokinetic aspects of retinal drug delivery","volume":"57","author":"del Amo","year":"2017","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.addr.2024.115321_b0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics12030269","article-title":"Drug delivery to the posterior segment of the eye: biopharmaceutic and pharmacokinetic considerations","volume":"12","author":"Varela-Fern\u00e1ndez","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.addr.2024.115321_b0140","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1517\/17425247.2014.935338","article-title":"Advances in ocular drug delivery: emphasis on the posterior segment","volume":"11","author":"Kang-Mieler","year":"2014","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.addr.2024.115321_b0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics14010134","article-title":"Topical drug delivery to the posterior segment of the eye","volume":"14","author":"L\u00f6scher","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.addr.2024.115321_b0150","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1080\/17425247.2018.1496080","article-title":"Recent advance of nanoparticle-based topical drug delivery to the posterior segment of the eye","volume":"15","author":"Wang","year":"2018","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.addr.2024.115321_b0155","doi-asserted-by":"crossref","unstructured":"S. Mohapatra, S. Ranjan, N. Dasgupta, R. Mishra, S. Thomas (Eds.), Nanocarriers for Drug Delivery, first ed., Elsevier, 2018. Doi: 10.1016\/C2017-0-00199-4.","DOI":"10.1016\/C2017-0-00199-4"},{"key":"10.1016\/j.addr.2024.115321_b0160","doi-asserted-by":"crossref","unstructured":"N. Mehra, S. Srivastava, J. Madan, P. Singh (Eds.), Multifunctional Nanocarriers, first ed., Elsevier, 2022. doi: 10.1016\/C2020-0-02236-X.","DOI":"10.1016\/C2020-0-02236-X"},{"key":"10.1016\/j.addr.2024.115321_b0165","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.ophtha.2014.09.036","article-title":"Clinical evaluation of Pazopanib eye drops versus Ranibizumab intravitreal injections in subjects with neovascular age-related macular degeneration","volume":"122","author":"Csaky","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.addr.2024.115321_b0170","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ejphar.2011.05.016","article-title":"Anti-angiogenic effects of the receptor tyrosine kinase inhibitor, pazopanib, on choroidal neovascularization in rats","volume":"666","author":"Yafai","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.addr.2024.115321_b0175","doi-asserted-by":"crossref","unstructured":"M. V\u00e9zina, Chapter 1 - Comparative ocular anatomy in commonly used laboratory animals, in: A.B. Weir, M. Collins (Eds.), Assess. Ocul. Toxicol. Lab. Anim., Humana Totowan, NJ, 2012, pp. 1\u201321. doi: 10.1007\/978-1-62703-164-6.","DOI":"10.1007\/978-1-62703-164-6_1"},{"key":"10.1016\/j.addr.2024.115321_b0180","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1089\/jop.2017.0099","article-title":"Characterization and pharmacokinetics of triamcinolone acetonide-loaded liposomes topical formulations for vitreoretinal drug delivery","volume":"34","author":"Altamirano-Vallejo","year":"2018","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.addr.2024.115321_b0185","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1080\/10717544.2019.1571122","article-title":"A more efficient ocular delivery system of triamcinolone acetonide as eye drop to the posterior segment of the eye","volume":"26","author":"Li","year":"2019","journal-title":"Drug Deliv."},{"key":"10.1016\/j.addr.2024.115321_b0190","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.ijbiomac.2019.10.256","article-title":"Chitosan coated liposomes (CCL) containing triamcinolone acetonide for sustained delivery: a potential topical treatment for posterior segment diseases","volume":"143","author":"Khalil","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.addr.2024.115321_b0195","doi-asserted-by":"crossref","first-page":"7289","DOI":"10.1167\/iovs.11-7983","article-title":"Edaravone-loaded liposome eyedrops protect against light-induced retinal damage in mice","volume":"52","author":"Shimazaki","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.addr.2024.115321_b0200","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1167\/iovs.09-4697","article-title":"Physicochemical properties affecting retinal drug\/ coumarin-6 delivery from nanocarrier systems via eyedrop administration","volume":"51","author":"Inokuchi","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.addr.2024.115321_b0205","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ejpb.2012.10.014","article-title":"Retinal drug delivery using eyedrop preparations of poly-l-lysine-modified liposomes","volume":"83","author":"Sasaki","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.addr.2024.115321_b0210","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1006\/bbrc.1996.0326","article-title":"Gene transfer to the retina of rat by liposome eye drops","volume":"219","author":"Matsuo","year":"1996","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.addr.2024.115321_b0215","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.ijpharm.2012.07.024","article-title":"Liposomal diclofenac eye drop formulations targeting the retina: formulation stability improvement using surface modification of liposomes","volume":"436","author":"Fujisawa","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2024.115321_b0220","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1002\/smll.201303433","article-title":"Topical delivery of avastin to the posterior segment of the eye in vivo using annexin A5-associated liposomes","volume":"10","author":"Davis","year":"2014","journal-title":"Small"},{"key":"10.1016\/j.addr.2024.115321_b0225","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18102076","article-title":"Topical ocular delivery of TGF-\u03b21 to the back of the eye: implications in age-related neurodegenerative diseases","volume":"18","author":"Platania","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.addr.2024.115321_b0230","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ejpb.2016.10.006","article-title":"Solid lipid nanoparticles as promising tool for intraocular tobramycin delivery: pharmacokinetic studies on rabbits","volume":"109","author":"Chetoni","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.addr.2024.115321_b0235","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.ijpharm.2015.08.088","article-title":"Lipid-polyethylene glycol based nano-ocular formulation of ketoconazole","volume":"495","author":"Kakkar","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2024.115321_b0240","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ejpb.2016.10.015","article-title":"Topical ophthalmic lipid nanoparticle formulations (SLN, NLC) of indomethacin for delivery to the posterior segment ocular tissues","volume":"109","author":"Balguri","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.addr.2024.115321_b0245","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s13346-020-00733-4","article-title":"Atorvastatin-loaded solid lipid nanoparticles as eye drops: proposed treatment option for age-related macular degeneration (AMD)","volume":"10","author":"Yadav","year":"2020","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.addr.2024.115321_b0250","first-page":"1","article-title":"In situ gel of triamcinolone acetonide-loaded solid lipid nanoparticles for improved topical ocular delivery: tear kinetics and ocular disposition studies","volume":"9","author":"Tatke","year":"2019","journal-title":"Nanomaterials"},{"key":"10.1016\/j.addr.2024.115321_b0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/nano10020287","article-title":"Ocular formulation based on palmitoylethanolamide-loaded nanostructured lipid carriers: technological and pharmacological profile","volume":"10","author":"Puglia","year":"2020","journal-title":"Nanomaterials"},{"key":"10.1016\/j.addr.2024.115321_b0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2018.00285","article-title":"Innovative nanoparticles enhance N-palmitoylethanolamide intraocular delivery","volume":"9","author":"Puglia","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.addr.2024.115321_b0265","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.colsurfb.2011.06.025","article-title":"Nanostructured lipid carriers for triamcinolone acetonide delivery to the posterior segment of the eye","volume":"88","author":"Ara\u00fajo","year":"2011","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.addr.2024.115321_b0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2019.118771","article-title":"Optimization, stabilization, and characterization of amphotericin B loaded nanostructured lipid carriers for ocular drug delivery","volume":"572","author":"Lakhani","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2024.115321_b0275","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1007\/s13346-020-00810-8","article-title":"Topical instillation of triamcinolone acetonide-loaded emulsomes for posterior ocular delivery: statistical optimization and in vitro-in vivo studies","volume":"11","author":"Kapadia","year":"2021","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.addr.2024.115321_b0280","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1080\/17425247.2020.1735348","article-title":"Penetratin-modified lutein nanoemulsion in-situ gel for the treatment of age-related macular degeneration","volume":"17","author":"Ge","year":"2020","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.addr.2024.115321_b0285","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ijpharm.2013.06.024","article-title":"Drug delivery to the ocular posterior segment using lipid emulsion via eye drop administration: effect of emulsion formulations and surface modification","volume":"453","author":"Ying","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2024.115321_b0290","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1080\/10717544.2019.1667455","article-title":"A novel dendrimer-based complex co-modified with cyclic RGD hexapeptide and penetratin for noninvasive targeting and penetration of the ocular posterior segment","volume":"26","author":"Yang","year":"2019","journal-title":"Drug Deliv."},{"key":"10.1016\/j.addr.2024.115321_b0295","doi-asserted-by":"crossref","first-page":"3814","DOI":"10.1002\/jps.24588","article-title":"In vitro\/in vivo evaluation of dexamethasone - PAMAM dendrimer complexes for retinal drug delivery","volume":"104","author":"Yavuz","year":"2015","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2024.115321_b0300","doi-asserted-by":"crossref","first-page":"19256","DOI":"10.1021\/acsami.6b04551","article-title":"Facile noninvasive retinal gene delivery enabled by penetratin","volume":"8","author":"Liu","year":"2016","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.addr.2024.115321_b0305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1167\/tvst.10.14.23","article-title":"A novel eye drop formulation for potential treatment of neovascular age-related macular degeneration","volume":"10","author":"Huang","year":"2021","journal-title":"Transl. Vis. Sci. Technol."},{"key":"10.1016\/j.addr.2024.115321_b0310","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1211\/jpp.59.5.0002","article-title":"Cyclodextrin microparticles for drug delivery to the posterior segment of the eye: aqueous dexamethasone eye drops","volume":"59","author":"Loftsson","year":"2010","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.addr.2024.115321_b0315","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ph14050480","article-title":"Bio-distribution and pharmacokinetics of topically administered \u03b3-cyclodextrin based eye drops in rabbits","volume":"14","author":"Kallab","year":"2021","journal-title":"Pharmaceuticals."},{"key":"10.1016\/j.addr.2024.115321_b0320","first-page":"1","article-title":"Antiangiogenic nanomicelles for the topical delivery of aflibercept to treat retinal neovascular disease","volume":"34","author":"Zhao","year":"2022","journal-title":"Adv. Mater."},{"key":"10.1016\/j.addr.2024.115321_b0325","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ejpb.2012.02.014","article-title":"Novel micelle carriers for cyclosporin A topical ocular delivery: in vivo cornea penetration, ocular distribution and efficacy studies","volume":"81","author":"Di Tommaso","year":"2012","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.addr.2024.115321_b0330","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1089\/jop.2014.0152","article-title":"Development and evaluation of dexamethasone nanomicelles with potential for treating posterior Uveitis after topical application","volume":"31","author":"Patel","year":"2015","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.addr.2024.115321_b0335","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1208\/s12249-014-0244-2","article-title":"Nanomicellar topical aqueous drop formulation of rapamycin for back-of-the-eye delivery","volume":"16","author":"Cholkar","year":"2015","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.addr.2024.115321_b0340","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ijpharm.2018.05.050","article-title":"Development of fluorometholone-loaded PLGA nanoparticles for treatment of inflammatory disorders of anterior and posterior segments of the eye","volume":"547","author":"Gonzalez-Pizarro","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2024.115321_b0345","first-page":"394","article-title":"Feasibility of drug delivery to the eye\u2019s posterior segment by topical instillation of PLGA nanoparticles","volume":"12","author":"Tahara","year":"2017","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.addr.2024.115321_b0350","first-page":"1","article-title":"Topical ocular delivery of nanoparticles with epoetin beta in Wistar Hannover rats","volume":"13","author":"Silva","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.addr.2024.115321_b0355","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2021.121379","article-title":"Development and optimization of Riluzole-loaded biodegradable nanoparticles incorporated in a mucoadhesive in situ gel for the posterior eye segment","volume":"612","author":"Esteruelas","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2024.115321_b0360","doi-asserted-by":"crossref","first-page":"4481","DOI":"10.2147\/IJN.S316564","article-title":"Hyaluronic-coated albumin nanoparticles for the non-invasive delivery of apatinib in diabetic retinopathy","volume":"16","author":"Radwan","year":"2021","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.addr.2024.115321_b0365","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1089\/jop.2020.0022","article-title":"Mucus-penetrating particles and the role of ocular mucus as a barrier to micro- and nanosuspensions","volume":"36","author":"Popov","year":"2020","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.addr.2024.115321_b0370","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1021\/acs.molpharmaceut.8b01136","article-title":"Multifunctional nanocomposites based on liposomes and layered double hydroxides conjugated with glycylsarcosine for efficient topical drug delivery to the posterior segment of the eye","volume":"16","author":"Gu","year":"2019","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.addr.2024.115321_b0375","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/polym13193324","article-title":"Hyaluronic acid-based gold nanoparticles for the topical delivery of therapeutics to the retina and the retinal pigment epithelium","volume":"13","author":"Laradji","year":"2021","journal-title":"Polymers (basel)."},{"key":"10.1016\/j.addr.2024.115321_b0380","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2021.120332","article-title":"Topical drug delivery to the posterior segment of the eye: thermodynamic considerations","volume":"597","author":"Sripetch","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2024.115321_b0385","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.addr.2008.09.008","article-title":"Barrier properties of mucus","volume":"61","author":"Cone","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2024.115321_b0390","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s13346-016-0339-2","article-title":"A comprehensive insight on ocular pharmacokinetics","volume":"6","author":"Agrahari","year":"2016","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.addr.2024.115321_b0395","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.1002\/adma.201201800","article-title":"Mucus penetrating nanoparticles: biophysical tool and method of drug and gene delivery","volume":"24","author":"Ensign","year":"2012","journal-title":"Adv. Mater."},{"key":"10.1016\/j.addr.2024.115321_b0400","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.copbio.2018.03.010","article-title":"Selective permeability of mucus barriers","volume":"52","author":"Witten","year":"2018","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.addr.2024.115321_b0405","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.ijpharm.2017.09.018","article-title":"Physicochemical properties of mucus and their impact on transmucosal drug delivery","volume":"532","author":"Leal","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2024.115321_b0410","doi-asserted-by":"crossref","first-page":"3","DOI":"10.5301\/EJO.2010.6049","article-title":"Blood-retinal barrier","volume":"21","author":"Cunha-Vaz","year":"2011","journal-title":"Eur. J. Ophthalmol."},{"key":"10.1016\/j.addr.2024.115321_b0415","doi-asserted-by":"crossref","unstructured":"T. A, S. PK, M. R, Role of blood retinal barrier in drug absorption, Pharm. Anal. Acta. 9 (2018) 1\u20135. doi: 10.4172\/2153-2435.1000585.","DOI":"10.4172\/2153-2435.1000585"},{"key":"10.1016\/j.addr.2024.115321_b0420","first-page":"1","article-title":"Targeted and reversible blood-retinal barrier disruption via focused ultrasound and microbubbles","volume":"7","author":"Park","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.addr.2024.115321_b0425","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/bdd.2276","article-title":"Blood retinal barrier and ocular pharmacokinetics: considerations for the development of oncology drugs","volume":"42","author":"Williamson","year":"2021","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.addr.2024.115321_b0430","series-title":"Drug Transp. Drug Dispos. Eff. Toxic.","first-page":"467","article-title":"Chapter 10 - Roles of drug transporters in blood-retinal barrier","author":"Liu","year":"2019"},{"key":"10.1016\/j.addr.2024.115321_b0435","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1089\/jop.2019.0017","article-title":"Organ-on-a-chip technologies for advanced blood-retinal barrier models","volume":"36","author":"Ragelle","year":"2020","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.addr.2024.115321_b0440","series-title":"Ocul. Transp. Recept. Their Role Drug Deliv","first-page":"1","article-title":"Chapter 1 - Eye: anatomy, physiology and barriers to drug delivery","author":"Cholkar","year":"2013"},{"key":"10.1016\/j.addr.2024.115321_b0445","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.drudis.2012.10.005","article-title":"Recent advances in topical ophthalmic drug delivery with lipid-based nanocarriers","volume":"18","author":"Gan","year":"2013","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.addr.2024.115321_b0450","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1016\/j.ophtha.2013.01.018","article-title":"Human corneal anatomy redefined: a novel pre-descemet\u2019s layer (Dua\u2019s Layer)","volume":"120","author":"Dua","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.addr.2024.115321_b0455","first-page":"1","article-title":"Nanocarrier mediated retinal drug delivery: overcoming ocular barriers to treat posterior eye diseases","volume":"10","author":"Bisht","year":"2018","journal-title":"Wiley Interdiscip. Rev. Nanomed. NanoBiotechnology"},{"key":"10.1016\/j.addr.2024.115321_b0460","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1038\/nprot.2010.137","article-title":"High-throughput microplate assay for the determination of drug partition coefficients","volume":"5","author":"Magalh\u00e3es","year":"2010","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.addr.2024.115321_b0465","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1586\/17512433.1.1.145","article-title":"Challenges and solutions in topical ocular drug-delivery systems","volume":"1","author":"Ali","year":"2008","journal-title":"Expert. Rev. Clin. Pharmacol."},{"key":"10.1016\/j.addr.2024.115321_b0470","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/j.drudis.2019.02.001","article-title":"Design principles of ocular drug delivery systems: importance of drug payload, release rate, and material properties","volume":"24","author":"Subrizi","year":"2019","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.addr.2024.115321_b0475","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1124\/dmd.116.069369","article-title":"Drug transport by the blood-aqueous humor barrier of the eye","volume":"44","author":"Lee","year":"2016","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.addr.2024.115321_b0480","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0039-6257(79)90158-9","article-title":"The blood-ocular barriers","volume":"23","author":"Cunha-Vaz","year":"1979","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.addr.2024.115321_b0485","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1089\/jop.2012.0138","article-title":"The vitreous humor as a barrier to nanoparticle distribution","volume":"29","author":"Mains","year":"2013","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.addr.2024.115321_b0490","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1080\/02713683.2020.1826977","article-title":"Macro- and microscale properties of the vitreous humor to inform substitute design and intravitreal biotransport","volume":"46","author":"Tram","year":"2021","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.addr.2024.115321_b0495","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fbioe.2018.00199","article-title":"Rheological properties and age-related changes of the human vitreous humor","volume":"6","author":"Tram","year":"2018","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.addr.2024.115321_b0500","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1080\/02713683.2019.1565890","article-title":"Morphology and composition of the inner limiting membrane: species-specific variations and relevance toward drug delivery research","volume":"44","author":"Peynshaert","year":"2019","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.addr.2024.115321_b0505","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics11090485","article-title":"Rational development of liposomal hydrogels : a strategy for topical vaginal antiretroviral drug delivery in the context of HIV prevention","volume":"11","author":"Faria","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.addr.2024.115321_b0510","first-page":"1","article-title":"Biophysical analysis on molecular interactions between chitosan-coated sinapic acid loaded liposomes and mucin","volume":"2024","author":"Prabakaran","year":"1868","journal-title":"Biochim. Biophys. Acta - Gen. Subj."},{"key":"10.1016\/j.addr.2024.115321_b0515","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics14091798","article-title":"Quality by design-driven zeta potential optimisation study of liposomes with charge imparting membrane additives","volume":"14","author":"N\u00e9meth","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.addr.2024.115321_b0520","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics15082078","article-title":"Nanostructured lipid carriers enriched hydrogels for skin topical administration of quercetin and omega-3 fatty acid","volume":"15","author":"L\u00facio","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.addr.2024.115321_b0525","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1517\/17425247.2011.586334","article-title":"Mucoadhesive nanomedicines: characterization and modulation of mucoadhesion at the nanoscale","volume":"8","author":"das Neves","year":"2011","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.addr.2024.115321_b0530","first-page":"1","article-title":"Nanomedicine approaches to negotiate local biobarriers for topical drug delivery","volume":"4","author":"Mustfa","year":"2021","journal-title":"Adv. Ther."},{"key":"10.1016\/j.addr.2024.115321_b0535","first-page":"1","article-title":"Target strategies for drug delivery bypassing ocular barriers","volume":"55","author":"Suri","year":"2020","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.addr.2024.115321_b0540","doi-asserted-by":"crossref","unstructured":"A. Mihai Grumezescu (Ed.), Organic Materials as Smart Nanocarriers for Drug Delivery, first ed., William Andrew Publishing, 2018. doi: 10.1016\/C2016-0-04124-4.","DOI":"10.1016\/C2016-0-04124-4"},{"key":"10.1016\/j.addr.2024.115321_b0545","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1023\/B:PHAM.0000022411.47059.76","article-title":"The characteristics and mechanisms of uptake of PLGA nanoparticles in rabbit conjunctival epithelial cell layers","volume":"21","author":"Qaddoumi","year":"2004","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2024.115321_b0550","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1211\/jpp.57.12.0005","article-title":"Size-dependent disposition of nanoparticles and microparticles following subconjunctival administration","volume":"57","author":"Amrite","year":"2010","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.addr.2024.115321_b0555","first-page":"150","article-title":"Effect of circulation on the disposition and ocular tissue distribution of 20 nm nanoparticles after periocular administration","volume":"14","author":"Amrite","year":"2008","journal-title":"Mol. Vis."},{"key":"10.1016\/j.addr.2024.115321_b0560","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics13020276","article-title":"Penetration enhancers for topical drug delivery to the ocular posterior segment \u2014 A systematic review","volume":"13","author":"Thareja","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.addr.2024.115321_b0565","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics11070321","article-title":"Penetration enhancers in ocular drug delivery","volume":"11","author":"Moiseev","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.addr.2024.115321_b0570","doi-asserted-by":"crossref","unstructured":"S.P. Vyas, R. Paliwal, S.R. Paliwal, Chapter 5 - Ocular delivery of peptides and proteins, in: C. Van Der Walle (Ed.), Pept. Protein Deliv., Elsevier, 2011, pp. 87\u2013103. doi: 10.1016\/B978-0-12-384935-9.10005-7.","DOI":"10.1016\/B978-0-12-384935-9.10005-7"},{"key":"10.1016\/j.addr.2024.115321_b0575","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/02713680802518251","article-title":"Molecular expression and functional evidence of a drug efflux pump (BCRP) in human corneal epithelial cells","volume":"34","author":"Karla","year":"2009","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.addr.2024.115321_b0580","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.3109\/10717544.2016.1138342","article-title":"A review on therapeutic contact lenses for ocular drug delivery","volume":"23","author":"Maulvi","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.addr.2024.115321_b0585","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jconrel.2013.01.018","article-title":"Nanoparticle diffusion in, and microrheology of, the bovine vitreous ex vivo","volume":"167","author":"Xu","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2024.115321_b0590","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1016\/j.bpj.2015.10.002","article-title":"Diffusion regulation in the vitreous humor","volume":"109","author":"K\u00e4sdorf","year":"2015","journal-title":"Biophys. J ."},{"key":"10.1016\/j.addr.2024.115321_b0595","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.addr.2017.09.007","article-title":"In vitro and ex vivo models to study drug delivery barriers in the posterior segment of the eye","volume":"126","author":"Peynshaert","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2024.115321_b0600","doi-asserted-by":"crossref","unstructured":"W. Halfter, J. Sebag, E.T. Cunningham, Chapter II.3: Vitreoretinal interface and inner limiting membrane, in: J. Sebag (Ed.), Vitr. Heal. Dis., Springer New York, NY, New York, 2014, pp. 165\u2013191.","DOI":"10.1007\/978-1-4939-1086-1_11"},{"key":"10.1016\/j.addr.2024.115321_b0605","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1016\/j.biomaterials.2012.01.030","article-title":"The movement of self-assembled amphiphilic polymeric nanoparticles in the vitreous and retina after intravitreal injection","volume":"33","author":"Koo","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2024.115321_b0610","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1080\/10717544.2017.1375578","article-title":"Toward smart design of retinal drug carriers: a novel bovine retinal explant model to study the barrier role of the vitreoretinal interface","volume":"24","author":"Peynshaert","year":"2017","journal-title":"Drug Deliv."},{"key":"10.1016\/j.addr.2024.115321_b0615","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.3109\/10717544.2014.943336","article-title":"Liposomes in topical ophthalmic drug delivery: an update","volume":"23","author":"Agarwal","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.addr.2024.115321_b0620","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics13020207","article-title":"Formulation considerations for the management of dry eye disease","volume":"13","author":"Agarwal","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.addr.2024.115321_b0625","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1080\/17425247.2016.1201059","article-title":"Application of lipid nanoparticles to ocular drug delivery","volume":"13","author":"Battaglia","year":"2016","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.addr.2024.115321_b0630","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clae.2021.101487","article-title":"Pharmaceutical-loaded contact lenses as an ocular drug delivery system: a review of critical lens characterization methodologies with reference to ISO standards","volume":"44","author":"Nguyen","year":"2021","journal-title":"Contact Lens Anterior Eye"},{"key":"10.1016\/j.addr.2024.115321_b0635","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1517\/17425247.2.2.201","article-title":"Transporters and receptors in ocular drug delivery: opportunities and challenges","volume":"2","author":"Dey","year":"2005","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.addr.2024.115321_b0640","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1124\/dmd.113.052704","article-title":"Expression of efflux transporters in human ocular tissues","volume":"41","author":"Chen","year":"2013","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.addr.2024.115321_b0645","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1159\/000108117","article-title":"Transport barriers in transscleral drug delivery for retinal diseases","volume":"39","author":"Kim","year":"2007","journal-title":"Ophthalmic Res."},{"key":"10.1016\/j.addr.2024.115321_b0650","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1167\/iovs.04-1051","article-title":"Permeability of retinal pigment epithelium: effects of permeant molecular weight and lipophilicity","volume":"46","author":"Pitk\u00e4nen","year":"2005","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.addr.2024.115321_b0655","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.addr.2017.12.008","article-title":"Implications of melanin binding in ocular drug delivery","volume":"126","author":"Rimpel\u00e4","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2024.115321_b0660","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/polym13071102","article-title":"Soft contact lenses as drug delivery systems: a review","volume":"13","author":"Franco","year":"2021","journal-title":"Polymers (basel)."},{"key":"10.1016\/j.addr.2024.115321_b0665","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fbioe.2020.00228","article-title":"Hydrogel biomaterials for application in ocular drug delivery","volume":"8","author":"Lynch","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.addr.2024.115321_b0670","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jconrel.2019.05.034","article-title":"Hydrogel-based ocular drug delivery systems: emerging fabrication strategies, applications, and bench-to-bedside manufacturing considerations","volume":"306","author":"Cooper","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2024.115321_b0675","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/gels7030130","article-title":"Gel-based materials for ophthalmic drug delivery","volume":"7","author":"Cassano","year":"2021","journal-title":"Gels"},{"key":"10.1016\/j.addr.2024.115321_b0680","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/polym14051010","article-title":"Polymeric nanoparticles-loaded hydrogels for biomedical applications: a systematic review on in vivo findings","volume":"14","author":"Nunes","year":"2022","journal-title":"Polymers (basel)."},{"key":"10.1016\/j.addr.2024.115321_b0685","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/j.drudis.2021.02.027","article-title":"Advanced nanodelivery platforms for topical ophthalmic drug delivery","volume":"26","author":"Gholizadeh","year":"2021","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.addr.2024.115321_b0690","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/molecules26185577","article-title":"Soft contact lenses as drug delivery systems: a review","volume":"26","author":"Rykowska","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.addr.2024.115321_b0695","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biomaterials.2019.119285","article-title":"Topical sustained drug delivery to the retina with a drug-eluting contact lens","volume":"217","author":"Ross","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2024.115321_b0700","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1021\/bc200151q","article-title":"Theranostics: combining imaging and therapy","volume":"22","author":"Kelkar","year":"2011","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.addr.2024.115321_b0705","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2217\/nnm-2019-0401","article-title":"Challenges of moving theranostic nanomedicine into the clinic","volume":"15","author":"Singh","year":"2020","journal-title":"Nanomedicine"},{"key":"10.1016\/j.addr.2024.115321_b0710","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s40336-014-0051-5","article-title":"The theranostic path to personalized nanomedicine","volume":"2","author":"Theek","year":"2014","journal-title":"Clin. Transl. Imaging."},{"key":"10.1016\/j.addr.2024.115321_b0715","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1177\/2472630317738699","article-title":"Theranostic nanoparticles for tracking and monitoring disease state","volume":"23","author":"Zavaleta","year":"2018","journal-title":"SLAS Technol."},{"key":"10.1016\/j.addr.2024.115321_b0720","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/sciadv.aba3252","article-title":"Wireless smart contact lens for diabetic diagnosis and therapy","volume":"6","author":"Keum","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.addr.2024.115321_b0725","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-022-34597-8","article-title":"Wireless theranostic smart contact lens for monitoring and control of intraocular pressure in glaucoma","volume":"13","author":"Kim","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.addr.2024.115321_b0730","doi-asserted-by":"crossref","first-page":"25487","DOI":"10.1021\/acsami.5b08644","article-title":"Surface-engineered contact lens as an advanced theranostic platform for modulation and detection of viral infection","volume":"7","author":"Mak","year":"2015","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.addr.2024.115321_b0735","doi-asserted-by":"crossref","first-page":"8188","DOI":"10.1021\/acs.analchem.8b01580","article-title":"Photostable and biocompatible fluorescent silicon nanoparticles-based theranostic probes for simultaneous imaging and treatment of ocular neovascularization","volume":"90","author":"Tang","year":"2018","journal-title":"Anal. Chem."},{"key":"10.1016\/j.addr.2024.115321_b0740","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2147\/DDDT.S91730","article-title":"Liposomal flucytosine capped with gold nanoparticle formulations for improved ocular delivery","volume":"10","author":"Salem","year":"2016","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.addr.2024.115321_b0745","first-page":"1","article-title":"A novel carbon dots\/thermo-sensitive in situ gel for a composite ocular drug delivery system: characterization, ex-vivo imaging and in vivo evaluation","volume":"22","author":"Wang","year":"2021","journal-title":"Int. J. Mol. Sci."}],"container-title":["Advanced Drug Delivery Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X24001431?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X24001431?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T02:25:10Z","timestamp":1777515910000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X24001431"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":149,"alternative-id":["S0169409X24001431"],"URL":"https:\/\/doi.org\/10.1016\/j.addr.2024.115321","relation":{},"ISSN":["0169-409X"],"issn-type":[{"value":"0169-409X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent advances and strategies for nanocarrier-mediated topical therapy and theranostic for posterior eye disease","name":"articletitle","label":"Article Title"},{"value":"Advanced Drug Delivery Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addr.2024.115321","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"115321"}}